![Beth San Segundo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Beth San Segundo
Directeur Général chez OriGen Biomedical, Inc.
Profil
Beth San Segundo is currently the President & Chief Executive Officer at OriGen Biomedical, Inc. She started this position in 2019.
Prior to her current role, she obtained an undergraduate degree from The University of Texas at Austin in 2002.
She later earned an MBA from St. Edward's University in 2014.
Postes actifs de Beth San Segundo
Sociétés | Poste | Début |
---|---|---|
OriGen Biomedical, Inc.
![]() OriGen Biomedical, Inc. Medical SpecialtiesHealth Technology OriGen Biomedical, Inc. engages in the manufacture of medical devices. Its ExtraCorporeal Membrane Oxygenation (ECMO) products are intended for supplementary oxygen support using a custom perfusion circuit instead of a respirator. It also manufactures specialty bags for cell culture and stem cell freezing in EVA, EVO, FEP, and Kapton/FEP compounds. The company was founded by Richard Martin in February 1996 and is headquartered in Austin, TX. | Directeur Général | 01/06/2019 |
Formation de Beth San Segundo
The University of Texas at Austin | Undergraduate Degree |
St. Edward's University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
OriGen Biomedical, Inc.
![]() OriGen Biomedical, Inc. Medical SpecialtiesHealth Technology OriGen Biomedical, Inc. engages in the manufacture of medical devices. Its ExtraCorporeal Membrane Oxygenation (ECMO) products are intended for supplementary oxygen support using a custom perfusion circuit instead of a respirator. It also manufactures specialty bags for cell culture and stem cell freezing in EVA, EVO, FEP, and Kapton/FEP compounds. The company was founded by Richard Martin in February 1996 and is headquartered in Austin, TX. | Health Technology |